Madrigal Pharmaceuticals
Earnings Surprise
Analysts estimated MDGL earnings of $-0.69 per share this quarter (Q4). MDGL's actual earnings were $-2.57 per share.
MDGL EPS surprise of -273.98%Analysts estimated MDGL earnings of $-2.12 per share this quarter (Q3). MDGL's actual earnings were $-4.96 per share.
MDGL EPS surprise of -133.61%Analysts estimated MDGL earnings of $-3.71 per share this quarter (Q2). MDGL's actual earnings were $-1.90 per share.
MDGL EPS surprise of 48.79%Analysts estimated MDGL earnings of $-3.76 per share this quarter (Q1). MDGL's actual earnings were $-3.32 per share.
MDGL EPS surprise of 11.70%Analysts estimated MDGL earnings of $-4.33 per share this quarter (Q4). MDGL's actual earnings were $-2.71 per share.
MDGL EPS surprise of 37.40%Analysts estimated MDGL earnings of $-7.05 per share this quarter (Q3). MDGL's actual earnings were $-4.92 per share.
MDGL EPS surprise of 30.22%Analysts estimated MDGL earnings of $-7.68 per share this quarter (Q2). MDGL's actual earnings were $-7.10 per share.
MDGL EPS surprise of 7.50%Analysts estimated MDGL earnings of $-6.41 per share this quarter (Q1). MDGL's actual earnings were $-7.38 per share.
MDGL EPS surprise of -15.12%Analysts estimated MDGL earnings of $-5.39 per share this quarter (Q4). MDGL's actual earnings were $-5.68 per share.
MDGL EPS surprise of 5.38%Analysts estimated MDGL earnings of $-5.02 per share this quarter (Q3). MDGL's actual earnings were $-5.34 per share.
MDGL EPS surprise of 6.30%